Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Sex and gender analysis improves science and engineering.

Tannenbaum C, Ellis RP, Eyssel F, Zou J, Schiebinger L.

Nature. 2019 Nov;575(7781):137-146. doi: 10.1038/s41586-019-1657-6. Epub 2019 Nov 6. Review.

PMID:
31695204
2.

Sex: a key consideration in understanding the etiology of psychiatric disorders and improving treatment

Tannenbaum C, Boksa P.

J Psychiatry Neurosci. 2019 Nov 1;44(6):364-366. doi: 10.1503/jpn.190165. No abstract available.

3.

Complexities in predicting deprescribing success using patients' beliefs and attitudes.

Turner JP, Martin P, Zhang YZ, Tannenbaum C.

Res Social Adm Pharm. 2019 Sep 5. pii: S1551-7411(19)30846-0. doi: 10.1016/j.sapharm.2019.09.004. [Epub ahead of print] No abstract available.

PMID:
31515073
4.

Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.

Tannenbaum CS, Rayman PA, Pavicic PG, Kim JS, Wei W, Polefko A, Wallace W, Rini BI, Morris-Stiff G, Allende DS, Hamilton T, Finke JH, Diaz-Montero CM.

Cancer Immunol Res. 2019 Oct;7(10):1687-1699. doi: 10.1158/2326-6066.CIR-18-0578. Epub 2019 Aug 22.

PMID:
31439615
5.

Policies for Deprescribing: An International Scan of Intended and Unintended Outcomes of Limiting Sedative-Hypnotic Use in Community-Dwelling Older Adults.

Shaw J, Murphy AL, Turner JP, Gardner DM, Silvius JL, Bouck Z, Gordon D, Tannenbaum C.

Healthc Policy. 2019 May;14(4):39-51. doi: 10.12927/hcpol.2019.25857.

PMID:
31322113
6.

Patients beliefs and attitudes towards deprescribing: can deprescribing success be predicted?

Turner JP, Martin P, Zhang YZ, Tannenbaum C.

Res Social Adm Pharm. 2019 Jul 10. pii: S1551-7411(19)30102-0. doi: 10.1016/j.sapharm.2019.07.007. [Epub ahead of print]

PMID:
31303479
7.
8.

Long-term effect of community-based continence promotion on urinary symptoms, falls and healthy active life expectancy among older women: cluster randomised trial.

Tannenbaum C, Fritel X, Halme A, van den Heuvel E, Jutai J, Wagg A.

Age Ageing. 2019 Jul 1;48(4):526-532. doi: 10.1093/ageing/afz038.

9.

An Implementation Guide to Promote Sleep and Reduce Sedative-Hypnotic Initiation for Noncritically Ill Inpatients.

Soong C, Burry L, Cho HJ, Gathecha E, Kisuule F, Tannenbaum C, Vijenthira A, Morgenthaler T.

JAMA Intern Med. 2019 Jul 1;179(7):965-972. doi: 10.1001/jamainternmed.2019.1196.

PMID:
31157831
10.

Pharmacist-Led Education to Discontinue Inappropriate Prescribing-Reply.

Tannenbaum C, Tamblyn R.

JAMA. 2019 Apr 2;321(13):1314. doi: 10.1001/jama.2019.0311. No abstract available.

PMID:
30938794
11.

Systematic Incorporation of Sex-Specific Information Into Clinical Practice Guidelines for the Management of ST -Segment-Elevation Myocardial Infarction: Feasibility and Outcomes.

Norris CM, Tannenbaum C, Pilote L, Wong G, Cantor WJ, McMurtry MS.

J Am Heart Assoc. 2019 Apr 2;8(7):e011597. doi: 10.1161/JAHA.118.011597.

12.

Sex-Specific Considerations in Guidelines Generation and Application.

Tannenbaum C, Norris CM, McMurtry MS.

Can J Cardiol. 2019 May;35(5):598-605. doi: 10.1016/j.cjca.2018.11.011. Epub 2018 Nov 24. Review.

13.

Sex, gender, and sports.

Tannenbaum C, Bekker S.

BMJ. 2019 Mar 20;364:l1120. doi: 10.1136/bmj.l1120. No abstract available.

PMID:
30894351
14.

Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature.

Bots SH, Groepenhoff F, Eikendal ALM, Tannenbaum C, Rochon PA, Regitz-Zagrosek V, Miller VM, Day D, Asselbergs FW, den Ruijter HM.

JACC Heart Fail. 2019 Mar;7(3):258-266. doi: 10.1016/j.jchf.2019.01.009.

15.

Is the belief that urinary incontinence is normal for ageing related to older Canadian women's experience of urinary incontinence?

Shaw C, Rajabali S, Tannenbaum C, Wagg A.

Int Urogynecol J. 2019 Feb 22. doi: 10.1007/s00192-019-03906-z. [Epub ahead of print]

PMID:
30796477
16.

Communication Techniques for Deprescribing Conversations #369.

Felton M, Tannenbaum C, McPherson ML, Pruskowski J.

J Palliat Med. 2019 Mar;22(3):335-336. doi: 10.1089/jpm.2018.0669. No abstract available.

PMID:
30794498
17.

Are gender gaps due to evaluations of the applicant or the science? A natural experiment at a national funding agency.

Witteman HO, Hendricks M, Straus S, Tannenbaum C.

Lancet. 2019 Feb 9;393(10171):531-540. doi: 10.1016/S0140-6736(18)32611-4.

PMID:
30739688
18.

Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8+ T cells from negative regulation by local IFN-γ.

Lin L, Rayman P, Pavicic PG Jr, Tannenbaum C, Hamilton T, Montero A, Ko J, Gastman B, Finke J, Ernstoff M, Diaz-Montero CM.

Cancer Immunol Immunother. 2019 Mar;68(3):395-405. doi: 10.1007/s00262-018-2280-3. Epub 2018 Dec 14.

PMID:
30552459
19.

Deprescribing conversations: a closer look at prescriber-patient communication.

Turner JP, Richard C, Lussier MT, Lavoie ME, Farrell B, Roberge D, Tannenbaum C.

Ther Adv Drug Saf. 2018 Oct 20;9(12):687-698. doi: 10.1177/2042098618804490. eCollection 2018 Dec.

20.

Performance of a Bayesian Approach for Imputing Missing Data on the SF-12 Health-Related Quality-of-Life Measure.

Halme AS, Tannenbaum C.

Value Health. 2018 Dec;21(12):1406-1412. doi: 10.1016/j.jval.2018.06.007. Epub 2018 Jul 24.

PMID:
30502784
21.

Strategies to promote public engagement around deprescribing.

Turner JP, Currie J, Trimble J, Tannenbaum C.

Ther Adv Drug Saf. 2018 Sep 12;9(11):653-665. doi: 10.1177/2042098618794165. eCollection 2018 Nov. Review.

22.

Patient-Oriented Policies To Reduce The Harmful Effects Of Medication On Seniors' Brain Function.

Daiello LA, Tannenbaum C.

Public Policy Aging Rep. 2018 Nov;28(4):124-128. doi: 10.1093/ppar/pry031. Epub 2018 Sep 28. No abstract available.

23.

Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.

Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C.

JAMA. 2018 Nov 13;320(18):1889-1898. doi: 10.1001/jama.2018.16131.

24.

Effectiveness of online learning on health researcher capacity to appropriately integrate sex, gender, or both in grant proposals.

Tannenbaum C, van Hoof K.

Biol Sex Differ. 2018 Aug 29;9(1):39. doi: 10.1186/s13293-018-0197-3.

25.

An Assessment Framework for e-Mental Health Apps in Canada: Results of a Modified Delphi Process.

Zelmer J, van Hoof K, Notarianni M, van Mierlo T, Schellenberg M, Tannenbaum C.

JMIR Mhealth Uhealth. 2018 Jul 9;6(7):e10016. doi: 10.2196/10016.

26.

Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.

Sun L, Funchain P, Song JM, Rayman P, Tannenbaum C, Ko J, Mcnamara M, Marcela Diaz-Montero C, Gastman B.

J Immunother Cancer. 2018 May 16;6(1):36. doi: 10.1186/s40425-018-0337-7.

27.

Does a Consumer-Targeted Deprescribing Intervention Compromise Patient-Healthcare Provider Trust?

Zhang YZ, Turner JP, Martin P, Tannenbaum C.

Pharmacy (Basel). 2018 Apr 16;6(2). pii: E31. doi: 10.3390/pharmacy6020031.

28.

A prototype for evidence-based pharmaceutical opinions to promote physician-pharmacist communication around deprescribing.

Martin P, Tannenbaum C.

Can Pharm J (Ott). 2018 Feb 8;151(2):133-141. doi: 10.1177/1715163518755813. eCollection 2018 Mar-Apr.

29.

EMPOWERing Hospitalized Older Adults to Deprescribe Sedative Hypnotics: A Pilot Study.

Wilson MG, Lee TC, Hass A, Tannenbaum C, McDonald EG.

J Am Geriatr Soc. 2018 Jul;66(6):1186-1189. doi: 10.1111/jgs.15300. Epub 2018 Mar 1.

PMID:
29492957
30.

Older Adults' Awareness of Deprescribing: A Population-Based Survey.

Turner JP, Tannenbaum C.

J Am Geriatr Soc. 2017 Dec;65(12):2691-2696. doi: 10.1111/jgs.15079. Epub 2017 Sep 15.

31.

Essential metrics for assessing sex & gender integration in health research proposals involving human participants.

Day S, Mason R, Tannenbaum C, Rochon PA.

PLoS One. 2017 Aug 30;12(8):e0182812. doi: 10.1371/journal.pone.0182812. eCollection 2017.

32.

A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.

Martin P, Tannenbaum C.

BMJ Open. 2017 May 4;7(4):e015959. doi: 10.1136/bmjopen-2017-015959.

33.

Sex in basic research: concepts in the cardiovascular field.

Ventura-Clapier R, Dworatzek E, Seeland U, Kararigas G, Arnal JF, Brunelleschi S, Carpenter TC, Erdmann J, Franconi F, Giannetta E, Glezerman M, Hofmann SM, Junien C, Katai M, Kublickiene K, König IR, Majdic G, Malorni W, Mieth C, Miller VM, Reynolds RM, Shimokawa H, Tannenbaum C, D'Ursi AM, Regitz-Zagrosek V.

Cardiovasc Res. 2017 Jun 1;113(7):711-724. doi: 10.1093/cvr/cvx066. Review.

PMID:
28472454
34.

Age and sex in drug development and testing for adults.

Tannenbaum C, Day D; Matera Alliance.

Pharmacol Res. 2017 Jul;121:83-93. doi: 10.1016/j.phrs.2017.04.027. Epub 2017 Apr 26. Review.

35.

Sex and gender considerations in Canadian clinical practice guidelines: a systematic review.

Tannenbaum C, Clow B, Haworth-Brockman M, Voss P.

CMAJ Open. 2017 Feb 10;5(1):E66-E73. doi: 10.9778/cmajo.20160051. eCollection 2017 Jan-Mar.

36.

Using eHealth Technologies: Interests, Preferences, and Concerns of Older Adults.

Ware P, Bartlett SJ, Paré G, Symeonidis I, Tannenbaum C, Bartlett G, Poissant L, Ahmed S.

Interact J Med Res. 2017 Mar 23;6(1):e3. doi: 10.2196/ijmr.4447.

37.

Sex and Gender Reporting in Research-Reply.

Clayton JA, Tannenbaum C.

JAMA. 2017 Mar 7;317(9):975. doi: 10.1001/jama.2017.0151. No abstract available.

PMID:
28267852
38.

Funding agency mechanisms to increase sex and gender analysis.

Duchesne A, Tannenbaum C, Einstein G.

Lancet. 2017 Feb 18;389(10070):699. doi: 10.1016/S0140-6736(17)30343-4. Epub 2017 Feb 17. No abstract available.

PMID:
28229876
39.

Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment.

Martin P, Tannenbaum C.

BMC Geriatr. 2017 Jan 31;17(1):37. doi: 10.1186/s12877-017-0432-5.

40.

An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network.

Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J, Turner J, Rochon P, Silvius J.

Can J Aging. 2017 Mar;36(1):97-107. doi: 10.1017/S0714980816000702. Epub 2017 Jan 16.

PMID:
28091333
41.

Strategies to Prevent or Reduce Gender Bias in Peer Review of Research Grants: A Rapid Scoping Review.

Tricco AC, Thomas SM, Antony J, Rios P, Robson R, Pattani R, Ghassemi M, Sullivan S, Selvaratnam I, Tannenbaum C, Straus SE.

PLoS One. 2017 Jan 6;12(1):e0169718. doi: 10.1371/journal.pone.0169718. eCollection 2017.

42.

Reporting Sex, Gender, or Both in Clinical Research?

Clayton JA, Tannenbaum C.

JAMA. 2016 Nov 8;316(18):1863-1864. doi: 10.1001/jama.2016.16405. No abstract available.

PMID:
27802482
43.

Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.

Najjar YG, Rayman P, Jia X, Pavicic PG Jr, Rini BI, Tannenbaum C, Ko J, Haywood S, Cohen P, Hamilton T, Diaz-Montero CM, Finke J.

Clin Cancer Res. 2017 May 1;23(9):2346-2355. doi: 10.1158/1078-0432.CCR-15-1823. Epub 2016 Oct 31.

44.

Why sex and gender matter in implementation research.

Tannenbaum C, Greaves L, Graham ID.

BMC Med Res Methodol. 2016 Oct 27;16(1):145.

45.

Innovative levers for sustainable integration of gender medicine into medical school curricula.

Tannenbaum C, Moineau G.

Biol Sex Differ. 2016 Oct 14;7(Suppl 1):41. eCollection 2016.

46.

Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada.

Boulin M, Diaby V, Tannenbaum C.

PLoS One. 2016 Sep 20;11(9):e0162951. doi: 10.1371/journal.pone.0162951. eCollection 2016.

47.

Genre, travail et vieillissement.

Tannenbaum C, Voss P, El-Gabalawy H, Joanette Y.

Can J Aging. 2016 Sep;35(3):412-9. doi: 10.1017/S0714980816000428. Epub 2016 Aug 1. No abstract available.

PMID:
27477250
48.

Gender, Work, and Aging.

Tannenbaum C, Voss P, El-Gabalawy H, Joanette Y.

Can J Aging. 2016 Sep;35(3):405-11. doi: 10.1017/S0714980816000416. Epub 2016 Jul 15. No abstract available.

PMID:
27418079
49.

Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study.

Morgan SG, Hunt J, Rioux J, Proulx J, Weymann D, Tannenbaum C.

CMAJ Open. 2016 Jun 22;4(2):E346-51. doi: 10.9778/cmajo.20150131. eCollection 2016 Apr-Jun.

50.

A survey of primary care patients' readiness to engage in the de-adoption practices recommended by Choosing Wisely Canada.

Silverstein W, Lass E, Born K, Morinville A, Levinson W, Tannenbaum C.

BMC Res Notes. 2016 Jun 10;9:301. doi: 10.1186/s13104-016-2103-6.

Supplemental Content

Loading ...
Support Center